Oramed Pharmaceuticals (ORMP) Receivables - Other (2011 - 2026)
Oramed Pharmaceuticals' (ORMP) quarterly Receivables - Other came in at $3.2 million in Q2 2023, up 3424.74% YoY from $91496.1 in Q2 2022, and up 3031.07% on a QoQ basis from $103000.0 in Q1 2023.
Oramed Pharmaceuticals (ORMP) Receivables - Other (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 9 years of Receivables - Other data on file, last reported at $3.2 million in Q2 2023.
- Quarterly Receivables - Other rose 3424.74% year-over-year to $3.2 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $2.6 million (up 183.02% YoY) and the FY2022 annual result came in at $376000.0, up 154.57% from the prior year.
- Receivables - Other grew to $3.2 million in Q2 2023, from $103000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $3.2 million in Q2 2023 to a low of -$3.3 million in Q3 2021.
- A 4-year average of -$54583.3 and a median of -$25500.0 in 2022 frame the typical range for Receivables - Other.
- The widest YoY moves for Receivables - Other: up 3424.74% in 2023, down 91.05% in 2023.
- Tracing ORMP's Receivables - Other over 4 years: stood at -$1.2 million in 2020, then grew by 14.92% to -$981000.0 in 2021, then surged by 104.69% to $46000.0 in 2022, then soared by 6910.87% to $3.2 million in 2023.
- The last three Receivables - Other figures came in at $3.2 million (Q2 2023), $103000.0 (Q1 2023), and $46000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Jun 30, 2026 | 1.00 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Mar 31, 2023 | 103,000.00 |
| Mar 31, 2023 | 103,000.00 |
| Dec 31, 2022 | 46,000.00 |
| Dec 31, 2022 | 46,000.00 |
| Sep 30, 2022 | -724,000.00 |
| Sep 30, 2022 | -724,000.00 |
| Jun 30, 2022 | -97,000.00 |
| Jun 30, 2022 | -97,000.00 |
| Mar 31, 2022 | 1.15 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Nov 30, 2021 | -981,000.00 |
| Nov 30, 2021 | -981,000.00 |
| Aug 31, 2021 | -3.27 Mn |
| Aug 31, 2021 | -3.27 Mn |
| May 31, 2021 | 172,000.00 |
| May 31, 2021 | 172,000.00 |